Please contact us through the qtox tool Download qtox https://github.com/qTox/qTox/blob/master/README.md#qtox If you can't contact us, please contact some data recovery company(suggest taobao.com), may they can contact to us. Add our TOX ID and send an encrypted file and 'Sorry-ID' for testing decryption. Our TOX ID: 3D7889AEC00F2325E1A3FBC0ACA4E521670497F11E47FDE13EADE8FED3144B5EB56D6B198724 PR news – RTK Group, LLC https://rtkgrp.com Fostering the Most Promising Pharmaceutical Advances Fri, 06 Jun 2025 13:47:22 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://rtkgrp.com/wp-content/uploads/2022/06/RTK-Favicon.png PR news – RTK Group, LLC https://rtkgrp.com 32 32 Unravel Biosciences Announces Submission of RVL-001 Clinical Study Applications for Rett Syndrome and Pitt Hopkins Syndrome to Colombian Health Regulatory Authority https://rtkgrp.com/prnews/unravel-biosciences-announces-submission-of-rvl-001-clinical-study-applications-for-rett-syndrome-and-pitt-hopkins-syndrome-to-colombian-health-regulatory-authority/ Tue, 29 Apr 2025 16:38:37 +0000 https://rtkgrp.com/?post_type=prnews&p=1081 Unravel Biosciences and COMBINED Brain Announce Large-Scale Drug Discovery Collaboration for Rare Neurological Diseases with High Unmet Need https://rtkgrp.com/prnews/unravel-biosciences-and-combined-brain-announce-large-scale-drug-discovery-collaboration-for-rare-neurological-diseases-with-high-unmet-need/ Thu, 27 Feb 2025 16:43:20 +0000 https://rtkgrp.com/?post_type=prnews&p=1082 Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults https://rtkgrp.com/prnews/scilex-holding-company-amends-its-license-agreement-with-romeg-therapeutics-llc-for-the-worldwide-rights-to-commercialize-gloperba-an-fda-approved-prophylactic-treatment-for-painful-gout-flar/ Thu, 16 Jan 2025 16:46:18 +0000 https://rtkgrp.com/?post_type=prnews&p=1085 Unravel Biosciences and PECET Announce Collaboration to Conduct Clinical Trials of RVL-001 in Rett Syndrome and Pitt Hopkins Syndrome in Colombia https://rtkgrp.com/prnews/unravel-biosciences-and-pecet-announce-collaboration-to-conduct-clinical-trials-of-rvl-001-in-rett-syndrome-and-pitt-hopkins-syndrome-in-colombia/ Thu, 24 Oct 2024 16:53:54 +0000 https://rtkgrp.com/?post_type=prnews&p=1089 Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label https://rtkgrp.com/prnews/scilex-holding-company-announces-fda-final-approval-to-precision-dosing-for-gloperba-label/ Thu, 29 Aug 2024 16:57:59 +0000 https://rtkgrp.com/?post_type=prnews&p=1090 Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024 https://rtkgrp.com/prnews/scilex-holding-company-announces-the-u-s-fda-has-approved-the-snda-for-commercial-manufacturing-of-gloperba-which-will-be-launched-in-the-us-in-the-week-of-june-10th-2024/ Thu, 06 Jun 2024 17:00:36 +0000 https://rtkgrp.com/?post_type=prnews&p=1092 Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett Syndrome https://rtkgrp.com/prnews/unravel-biosciences-receives-fda-orphan-drug-designation-for-vorinostat-rvl-001-as-a-treatment-for-rett-syndrome/ Tue, 28 May 2024 17:04:33 +0000 https://rtkgrp.com/?post_type=prnews&p=1093 Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed https://rtkgrp.com/prnews/scilex-holding-company-announces-seeking-approval-from-the-fda-for-modification-of-the-gloperba-label-to-provide-specific-dosing-guidance-for-patients-with-renal-impairment-and-other-circumstanc/ Wed, 20 Mar 2024 17:06:45 +0000 https://rtkgrp.com/?post_type=prnews&p=1095 Scilex Holding Company announces completion of commercial manufacturing of Gloperba® with the brand marketed and distributed under Scilex Pharmaceuticals, Inc. and is expecting to Launch in the U.S. in the first quarter of 2024 https://rtkgrp.com/prnews/scilex-holding-company-announces-completion-of-commercial-manufacturing-of-gloperba-with-the-brand-marketed-and-distributed-under-scilex-pharmaceuticals-inc-and-is-expecting-to-launch-in-the-u/ Mon, 27 Nov 2023 17:09:20 +0000 https://rtkgrp.com/?post_type=prnews&p=1096 Unravel Biosciences Announces Positive Feedback From FDA PRE-IND Meeting on RVL001 Rett Syndrome Program https://rtkgrp.com/prnews/unravel-biosciences-announces-positive-feedback-from-fda-pre-ind-meeting-on-rvl001-rett-syndrome-program/ Wed, 15 Feb 2023 17:11:24 +0000 https://rtkgrp.com/?post_type=prnews&p=1098